Key result
Nuclear receptors control inflammatory transcription pathways, offering potential therapeutic targets for chronic atherosclerosis.
Answers are grounded in this paper and cite their sources.
Tissue inflammation is a tightly regulated process that normally serves to recruit the immune system to sites of infection and injury and to facilitate tissue repair processes. When an inflammatory state is excessive or prolonged, local and systemic damage to host tissues can result in loss of normal physiological functions. Here, we briefly review recent studies that advance our understanding of signaling pathways involved in initiation of inflammatory responses at the level of transcription and counterregulation of these pathways by selected members of the nuclear receptor superfamily. Studies of the intersection of nuclear receptors and inflammation have revealed mechanisms of positive and negative transcriptional control that may provide new targets for pharmacological intervention in chronic diseases, such as atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2010) conducted a review in Inflammation. Nuclear receptors was evaluated. Nuclear receptors intersect with inflammatory pathways to provide transcriptional control, revealing potential new targets for pharmacological intervention in chronic diseases like atherosclerosis.
Synapse has enriched 10 related papers. Consider them for comparative context: